Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
Seroquel XR and Seroquel Approved in Europe for Prevention of Recurrence of Bipolar Disorder
-
Brilinta Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
-
US Court of Appeals Affirms Summary Judgment Decision in Seroquel Patent Litigation
-
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes to Address Opioid-Induced Constipation
-
AstraZeneca Announces FDA Acceptance of New Drug Application for VIMOVO
-
Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
-
AstraZeneca and Forest Laboratories to Co-Develop and Commercialise a Late Stage Next Generation Anti-Infective
-
AstraZeneca And Astellas Enter Agreement for Co-Promotion of Symbicort Turbuhaler in Japan
-
FDA Approves ONGLYZA For The Treatment Of Type 2 Diabetes In The US
-
AstraZeneca PLC Second Quarter & Half Year Results 2009
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rob Skelding
Director Global Media Relations (Oncology)
+44 203 749 5821
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
